After a new agreement, the NHS will have access to transformative mRNA technology

Following the Government's agreement with Moderna to establish a cutting-edge manufacturing facility in the UK, NHS patients will now have access to the most recent technological developments, therapies, and vaccinations, including "transformative" mRNA technology.

The new...

A husband-and-wife team of scientists pleaded guilty to illegally importing potentially toxic lab chemicals and sending confidential mRNA vaccine research to China

Chenyan Wu and Lianchun Chen, a married couple who worked as research scientists for a major American pharmaceutical company, pleaded guilty today in federal court to criminal charges stemming from their efforts to obtain confidential mRNA research from that company to advance their husband's...

Just weeks after unveiling its first COVID-19 vaccine prototype, the WHO's mRNA technology is moving to Asia and Europe

 So far, the initiative has generated a prototype COVID-19 vaccine that is comparable to Moderna's but not identical. It's based on the same publicly accessible sequence, but due to Moderna's unwillingness to help (beyond pledging not to pursue its patents during the epidemic), W...

Global mRNA Vaccines Market Research Report [2021-2029] - A Report by Absolute Markets Insights

According to a report published by AMI, the global mRNA vaccines market is anticipate to grow at a CAGR of 19.76% during the forecast period. The rapid advancement in medical technology that promotes the development of mRNA vaccines, coupled with the growth of infectious diseases globally is a ma...

Moderna Vaccine to be Manufactured in Australia

Australia is planning to produce the Moderna vaccine for the Covid-19. The country plans on putting together 100 million shots per year.

An agreement has been signed between Moderna, Australia’s federal government, and the government of Victoria to set up a facility in Victoria by...

CureVac to begin clinical trials for second-generation COVID-19 vaccine

German biotechnology company CureVac said on November 18 that clinical trials for its second-generation COVID-19 vaccine will begin in the next few months.

Highlights

• CureVac to begin clinical trials of its second-generation COVID-19 vaccine

SOUTH KOREAN PM SAYS COUNTRY TO SECURE MORE mRNA VACCINES TO USE THEM AS A BOOSTER SHOT

Highlights

• Kim said "The government plans to first secure vaccine supply, mostly mRNA ones, enough to vaccinate the entire public with at least one shot next year.”

According to a statement by the Prime Minister of South Korea, Kim Boo-kyum is planning to sec...

CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH

Highlights –

• China developed mRNA vaccine likely to start trials next month.
• The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
• The vaccine may get overseas approval to conduct Phase II...

DR FAUCI: MODERNA’S COVID19 VACCINE SHOWS PROMISE

Highlights:

• Human trials of the covid19 vaccine developed by Moderna began in March 2020
• The data gathered so far display hope
• Moderna is yet to make any detailed official statement as yet

Moderna effectively began human testing its covid1...